Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

IMAC Holdings

Nasdaq:IMAC
Snowflake Description

Overvalued with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
IMAC
Nasdaq
$16M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. The last earnings update was 8 days ago. More info.


Add to Portfolio Compare Print
  • IMAC Holdings has significant price volatility in the past 3 months.
IMAC Share Price and Events
7 Day Returns
-19.8%
NasdaqCM:IMAC
1.9%
US Healthcare
-1.1%
US Market
1 Year Returns
-71%
NasdaqCM:IMAC
-1.7%
US Healthcare
-13.6%
US Market
IMAC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
IMAC Holdings (IMAC) -19.8% 88.1% 0.6% -71% - -
US Healthcare 1.9% -10.3% -16.7% -1.7% 14.9% 15.7%
US Market -1.1% -17.8% -22.5% -13.6% 4.9% 16.3%
1 Year Return vs Industry and Market
  • IMAC underperformed the Healthcare industry which returned -1.7% over the past year.
  • IMAC underperformed the Market in United States of America which returned -13.6% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is IMAC Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for IMAC Holdings. This is due to cash flow or dividend data being unavailable. The share price is $1.58.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for IMAC Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are IMAC Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:IMAC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.84
NasdaqCM:IMAC Share Price ** NasdaqCM (2020-04-02) in USD $1.58
United States of America Healthcare Industry PE Ratio Median Figure of 45 Publicly-Listed Healthcare Companies 20.62x
United States of America Market PE Ratio Median Figure of 2,943 Publicly-Listed Companies 12.9x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of IMAC Holdings.

NasdaqCM:IMAC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:IMAC Share Price ÷ EPS (both in USD)

= 1.58 ÷ -0.84

-1.89x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • IMAC Holdings is loss making, we can't compare its value to the US Healthcare industry average.
  • IMAC Holdings is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does IMAC Holdings's expected growth come at a high price?
Raw Data
NasdaqCM:IMAC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.89x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Healthcare Industry PEG Ratio Median Figure of 32 Publicly-Listed Healthcare Companies 1.59x
United States of America Market PEG Ratio Median Figure of 2,006 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for IMAC Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on IMAC Holdings's assets?
Raw Data
NasdaqCM:IMAC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $1.12
NasdaqCM:IMAC Share Price * NasdaqCM (2020-04-02) in USD $1.58
United States of America Healthcare Industry PB Ratio Median Figure of 95 Publicly-Listed Healthcare Companies 2.29x
United States of America Market PB Ratio Median Figure of 5,140 Publicly-Listed Companies 1.25x
NasdaqCM:IMAC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:IMAC Share Price ÷ Book Value per Share (both in USD)

= 1.58 ÷ 1.12

1.41x

* Primary Listing of IMAC Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • IMAC Holdings is good value based on assets compared to the US Healthcare industry average.
X
Value checks
We assess IMAC Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. IMAC Holdings has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is IMAC Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IMAC Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.6%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is IMAC Holdings expected to grow at an attractive rate?
  • Unable to compare IMAC Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare IMAC Holdings's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare IMAC Holdings's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:IMAC Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.6%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:IMAC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:IMAC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 15 -4 -6
2019-09-30 14 -3 -6
2019-06-30 12 -3 -5
2019-03-31 9 -2 -4
2018-12-31 7 -2 -3
2018-09-30 4 -2 -2
2018-06-30 2 -1 -1
2018-03-31 1 -1 -1
2017-12-31 1 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if IMAC Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if IMAC Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:IMAC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from IMAC Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:IMAC Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.84
2019-09-30 -0.89
2019-06-30 -0.94
2019-03-31 -0.87
2018-12-31 -0.67
2018-09-30 -0.49
2018-06-30 -0.27
2018-03-31 -0.12
2017-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if IMAC Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of IMAC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. IMAC Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. IMAC Holdings's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess IMAC Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
IMAC Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has IMAC Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare IMAC Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • IMAC Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare IMAC Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare IMAC Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
IMAC Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from IMAC Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:IMAC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 15.13 -6.50 6.70
2019-09-30 14.16 -5.99 6.50
2019-06-30 12.33 -5.42 6.05
2019-03-31 9.20 -4.25 4.93
2018-12-31 6.70 -3.05 3.94
2018-09-30 3.79 -2.24 2.75
2018-06-30 1.57 -1.24 1.60
2018-03-31 1.02 -0.55 0.92
2017-12-31 0.79 -0.06 0.60
2016-12-31 0.02 -0.38 0.20

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if IMAC Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if IMAC Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if IMAC Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess IMAC Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
IMAC Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is IMAC Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up IMAC Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • IMAC Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • IMAC Holdings's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of IMAC Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from IMAC Holdings Company Filings, last reported 3 months ago.

NasdaqCM:IMAC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 7.94 3.61 0.37
2019-09-30 7.76 3.65 0.74
2019-06-30 9.29 3.68 2.23
2019-03-31 7.09 3.54 3.07
2018-12-31 -3.93 5.16 0.19
2018-09-30 -3.04 4.59 0.24
2018-06-30 -1.79 4.02 0.21
2018-03-31 -0.26 2.96 0.55
2017-12-31 0.17 0.64 0.13
2016-12-31 1.05 0.50 0.88
  • IMAC Holdings's level of debt (45.5%) compared to net worth is high (greater than 40%).
  • Unable to establish if IMAC Holdings's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • IMAC Holdings has less than a year of cash runway based on current free cash flow.
  • IMAC Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 36.2% each year.
X
Financial health checks
We assess IMAC Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. IMAC Holdings has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is IMAC Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from IMAC Holdings dividends.
If you bought $2,000 of IMAC Holdings shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate IMAC Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate IMAC Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:IMAC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 1.8%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1943 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as IMAC Holdings has not reported any payouts.
  • Unable to verify if IMAC Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of IMAC Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as IMAC Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess IMAC Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can IMAC Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. IMAC Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of IMAC Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jeff Ervin
COMPENSATION $1,451,877
AGE 41
TENURE AS CEO 5.1 years
CEO Bio

Mr. Jeffrey S. Ervin, also known as Jeff, is Chairman, Chief Executive Officer & Co-Founder of IMAC Holdings since March 2015. Mr. Ervin earned his M.B.A. from Vanderbilt University and has a history of working within strategic finance roles in the healthcare and high tech industries. Following his M.B.A., Mr. Ervin was the Senior Financial Analyst and Vice President of Finance for the Baptist Hospital System of Nashville from 2006 to September 2011, responsible for sourcing and managing direct investments to satisfy pension obligations. After these five years, Mr. Ervin joined Medicare.com parent Medx Publishing in October 2011 as the senior financial officer tasked with building administrative functions to satisfy rapid growth in the CMS education sector. During this time through March 2015, Medicare.com earned INC. 500 recognition and he was instrumental in the acquisition of Medicaid.com which was sold to United Healthcare Group. Mr. Ervin was also responsible for the disposition and ultimate sale of Medicare.com to eHealth Insurance.

CEO Compensation
  • Jeff's compensation has increased whilst company is loss making.
  • Jeff's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the IMAC Holdings management team in years:

3.4
Average Tenure
44.5
Average Age
  • The tenure for the IMAC Holdings management team is about average.
Management Team

Jeff Ervin

TITLE
Chairman & CEO
COMPENSATION
$1M
AGE
41
TENURE
5.1 yrs

Sheri Gardzina

TITLE
Interim CFO & Corporate Secretary
COMPENSATION
$465K
AGE
50
TENURE
1 yrs

Matthew Wallis

TITLE
COO & Director
COMPENSATION
$257K
AGE
45
TENURE
5.1 yrs

Jeff Ervin

TITLE
Chief Executive Officer

Ian White

TITLE
Chief Scientific Officer
AGE
44
TENURE
1.7 yrs
Board of Directors Tenure

Average tenure and age of the IMAC Holdings board of directors in years:

1.2
Average Tenure
49
Average Age
  • The average tenure for the IMAC Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Jeff Ervin

TITLE
Chairman & CEO
COMPENSATION
$1M
AGE
41
TENURE
5.1 yrs

Matthew Wallis

TITLE
COO & Director
COMPENSATION
$257K
AGE
45
TENURE
5.1 yrs

Deke Ellwanger

TITLE
Independent Director
COMPENSATION
$134K
AGE
63
TENURE
1.2 yrs

George Hampton

TITLE
Independent Director
COMPENSATION
$134K
AGE
49
TENURE
1.2 yrs

Gerry Hayden

TITLE
Independent Director
AGE
64
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
20. Nov 19 Buy Jeffrey Ervin Individual 18. Nov 19 19. Nov 19 1,200 $2.26 $2,544
X
Management checks
We assess IMAC Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. IMAC Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of March 26, 2020, the company owned or managed 14 outpatient clinics in Kentucky, Missouri, Tennessee, and Illinois. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.

Details
Name: IMAC Holdings, Inc.
IMAC
Exchange: NasdaqCM
Founded: 2000
$15,814,373
10,009,097
Website: http://www.imacregeneration.com
Address: IMAC Holdings, Inc.
1605 Westgate Circle,
Brentwood,
Tennessee, 37027,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM IMAC Common Stock Nasdaq Capital Market US USD 13. Feb 2019
DB I02 Common Stock Deutsche Boerse AG DE EUR 13. Feb 2019
Number of employees
Current staff
Staff numbers
120
IMAC Holdings employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/03 02:41
End of day share price update: 2020/04/02 00:00
Last earnings filing: 2020/03/26
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.